Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q1 2024 Pharmacy & Infusion Services Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q1 2024 Pharmacy & Infusion Services Update

Healthcare providers continue to expand upon their infusion service lines and tactics as site-of-care strategies grow in importance. This change has led to several new platforms being created, including New Harbor’s latest investment to form Access Infusion Care. Deal flow is being fueled by the ongoing shift of site-of-care from hospitals to outpatient settings including AICs, OICs, and the home. While each setting has its own pros and cons, home infusion offers various benefits that better cater to the needs of patients, including cost-effectiveness and better outcomes, a trend that many investors and strategic acquirers are looking to capitalize on.

Another rapidly changing pharmaceutical services sector is specialty pharmacy, which historically has seen margin pressure due to stress on reimbursement which has discouraged investment in the space. However, evolving business models that create sticky relationships with health systems, manufacturers, and/or patients are becoming more prominent and attracting private equity investment again.

To print and download the full Pharmacy & Infusion Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q1-2024-Pharmacy-Infusion-Services-Newsletter-vF.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]